CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenues	$ 5,660,427	$ 2,739,439
Cost of revenue	2,626,815	1,384,145
Gross profit	3,033,612	1,355,294
Operating expenses:
Selling and marketing	2,462,865	1,421,127
Research and development	194,429	181,303
General and administrative	4,950,138	4,271,510
Total operating expenses	7,607,432	5,873,940
Operating loss	(4,573,820)	(4,518,646)
Other income (expense):
Unrealized loss on derivative liabilities	0	(155,027)
Unrealized loss on marketable securities	(240)	(450)
Loss on settlement of debt	(267,812)	(15,724)
Interest income (expense), net	(178,002)	(917,992)
Total other (expenses) income	(446,054)	(1,089,193)
Net loss	(5,019,874)	(5,607,839)
Dividends on Series A convertible preferred stock	(53,740)	(75,206)
Net loss available to common stockholders	$ (5,073,614)	$ (5,683,045)
Net loss per common share-basic and diluted	$ (0.74)	$ (1.21)
Weighted average common shares outstanding-basic and diluted	6,892,238	4,693,437